New Consensus Guideline Backs Curative Intent in Metastatic NPC

An international guideline developed by 54 experts across 46 centres and endorsed by 17 oncology organisations provides 32 recommendations for managing de novo metastatic nasopharyngeal carcinoma, including 29 strong and three conditional recommendations. The guideline states that curative-intent treatment should be offered to medically fit patients with no more than three metastatic lesions in two or fewer organs at baseline or after response to systemic therapy, recommending multimodality treatment combining immunochemotherapy, locoregional radiotherapy, metastasis-directed therapy, and maintenance therapy. The authors note this provides a framework for standardising clinical management and identifying evidence gaps for future research.

Most relevant for: Patients with newly diagnosed metastatic nasopharyngeal carcinoma who are medically fit and have limited metastatic burden.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.